U.S. Supreme Court Denies Celanese Petition in Acesulfame Potassium Patent Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Celanese Corp. v. International Trade Commission |
| Case Number | 24-635 (U.S. Supreme Court) |
| Court | U.S. Supreme Court, District of Columbia |
| Duration | Dec 2024 – Apr 2025 140 days |
| Outcome | Petition Denied |
| Patents at Issue | |
| Subject Matter | Acesulfame Potassium Compositions & Production Processes |
Case Overview
The Parties
⚖️ Petitioner (Celanese)
Global specialty materials company with a diversified portfolio spanning engineered materials, acetyl chain chemicals, and food ingredient technologies, including acesulfame potassium.
🛡️ Respondent (ITC)
U.S. federal agency empowered to investigate unfair trade practices, including patent infringement in imported goods, and adjudicate patentability.
Patents at Issue
Three U.S. patents were central to this proceeding, all relating to acesulfame potassium compositions and processes for producing same—a zero-calorie artificial sweetener widely used in food, beverage, and pharmaceutical applications:
- • US10590095B2 (Application No. US16/273358)
- • US10023546B2 (Application No. US15/704457)
- • US10208004B2 (Application No. US16/014552)
Developing similar chemical processes or compositions?
Check if your technology might be affected by these or related patents.
The Verdict & Legal Analysis
Outcome
The U.S. Supreme Court denied Celanese’s petition, with the basis of termination recorded as Petition Dismissed. This denial effectively leaves intact the ITC’s findings adverse to Celanese on the validity of US10590095B2, US10023546B2, and US10208004B2.
Key Legal Issues
The Supreme Court’s refusal to grant certiorari reinforces the International Trade Commission’s authority over patentability determinations in specialty chemical patent disputes. The denial signals the Court’s continued deference to ITC and administrative patent review bodies when invalidity or cancellation actions are at issue.
This case highlights the risk of prosecution strategies that rely on closely related continuation or continuation-in-part applications—a challenger defeating one application’s validity claims may cascade that success across the portfolio.
Filing a chemical composition or process patent?
Learn from this case. Use AI to draft stronger claims that can withstand validity challenges.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Critical IP Risks in Specialty Chemicals
This case highlights the importance of thorough patentability analysis for chemical compositions. Choose your next step:
📋 Understand This Case’s Implications
Learn about the specific risks and strategic implications from this litigation.
- Review validity challenges in chemical composition patents
- Understand the ITC’s role in patentability determinations
- Analyze implications for acesulfame potassium IP
🔍 Check My Product/Process Risk
Run a comprehensive FTO analysis for your own chemical technology or product.
- Input your chemical composition or process description
- AI identifies potentially blocking chemical patents
- Get actionable invalidity and infringement risk assessment
ITC Authority Affirmed
Over patentability determinations
3 Patents Affected
Celanese’s acesulfame potassium portfolio
Invalidity Strategy
Key for chemical patent litigation
✅ Key Takeaways
For Patent Attorneys & Litigators
Supreme Court certiorari denial after ITC invalidity findings leaves administrative patent cancellations effectively final in practical terms.
Search related case law →Three-patent family invalidation illustrates cascading risk in continuation-heavy prosecution strategies.
Explore precedents →For IP Professionals & R&D Teams
R&D teams developing competing acesulfame potassium formulations should conduct FTO analyses against the surviving IP landscape.
Start FTO analysis for my product →Consider the vulnerability of closely related patent families in chemical composition and process patents.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.